Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Legacy shareholders are down 99.x % over fifteen years. LP is up tens of millions.
>>keeping the value of this platform technology 100% in the hands of investors
Enlighten us please.
>>and they have admitted to certain things that they could have done better.
Yes, and that's exactly when a BP should step in to buy a small biotech for a handsome premium making the acquirer and common very happy. Never happened, of course, and LP was just full of nonsense.
>>No cult. I just recognize the reality. And I would not have invested much 12 years ago because honestly, I’ve known enough bios to know that they had a long way to go. I was watching them then.
So, 13 years ago LP says they're good to go with cost issues and profitability with a vaccine showing good results and practically no side effects. Since then the company has lost its retail shareholders 99% plus of their investment and gone into hiding. BioHarm says management is doing a great job. LOL
Nonsense?!!! LOL. It's their own false words...their own history. What you fail to recognize is that with NWBO it's all the crew! No management shakeups ever except for those who disappeared, of course.
https://www.linkedin.com/in/anthony-maida-9b159b247
So from lab to FDA approval of a drug with some serious side effects takes 11 years. Makes sense. DC's started in the early 90's.
Correct call from 2014.
>>The DCVax PIM designation will prove to be as meaningless as the German "hospital exemption" announced in March.
Correct:
>>The buyers of Northwest's convertible notes want the company's stock price to decline before Feb. 15, 2015, because a lower stock price will also drop the conversion price of the debt when it resets. A lower conversion price means note holders get more and cheaper Northwest shares to sell when they convert the notes. The Northwest debt holders also make extra money by shorting the stock and covering lower.
>>And Northwest will be happy to make its convertible notes more profitable for current holders at the expense of equity shareholders because when the company needs to raise cash again next year (and Northwest will definitely raise more money next year) it will find a receptive audience. Vulture investors love distressed companies who make it easy to book profits.
https://www.thestreet.com/investing/northwest-bios-almost-toxic-debt-raise-responsible-for-stock-slide-12885672
2011.
>>DCVax® immune therapies for a broad range of cancers (including prostate, brain, ovarian and others) hold the promise, based on available data to date, of being cost effective and priced below other immune therapies while still providing substantial profit margins for the Company and longer survival for patients.
https://www.biospace.com/article/releases/northwest-biotherapeutics-highlights-cost-effectiveness-of-dcvax-in-view-of-recent-immunotherapy-pricing-concerns-408411/
2011.
>>Linda Powers, CEO of NORTHWEST BIO, commented that "It is gratifying to see that the expanded management team put in place in June is moving the GBM clinical trial forward at an accelerating rate, while taking important steps toward strengthening our investor and media outreach."
https://www.fiercebiotech.com/biotech/northwest-bio-announces-positive-third-quarter-progress
Remarkable how you guys just refuse to get it. What else have they accomplished in a decade?
>>And sure hope that they didn’t take half a decade from data lock to just prepare an application and submit and wait for the decision to just one RA
They're a disaster. Zero energy coming from this company. It feels empty. Without a quick buyout this thing is toast, IMO.
I might need to change my mind on chemo soon.
https://neurosciencenews.com/glioblastoma-cancer-pathway-26147/
And speaking of loons, I see DanishDancer chimed in with another whopper.
"If fudders beg for governance and for retailers getting informed, you can rest asssured they want that in order to be able to manipulate the share price.
Its the essence of logic and reason. "
With each sentence everyone can see now that you're a loon but this one really stands out.
>>Linda Powers, the intelligent woman that she is, has been the shorts absolute worst enemy.
You could've shortened this one up to Management is executing retail.
Keep it simple. Les keeps it down whenever he does BBS appearance telling the Street they have no buyers. To make matters even worse this time he told shorts he's got 50k retail shareholders and to expect to hear from the MHRA in the fall.
Well, you at least have this part right. They've kept the company hanging on by a thread forever assuring no real analyst coverage or Street interest, just a bunch of sappy powerless retail shareholders so LP can continue do her private work without interference.
I know it's difficult, disciples, but you can do it!
Apologies for posting here about GBM patients and therapies. Wrong board.
Faith no more! Theralink going dark. Great work Faith, Mick and especially Big Al. That's quite a track record you've made for yourself. LOL
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Approximate number of holders of record as of the certification or notice date: 237.
Shrugs.
>>Former colleagues in Congress put her in touch with Dr. Henry Friedman, a neuro-oncologist and deputy director of the Preston Robert Tisch Brain Tumor Center at Duke University in North Carolina.
https://www.deseret.com/politics/2024/05/16/mia-love-glioblastoma-brain-cancer-update/
https://www.survivornet.com/articles/polio-virus-injected-to-fight-brain-cancer-the-new-research-since-sen-john-mccain-died-5-years-ago-hear-from-one-of-the-countrys-leading-experts/
This company filed a 13g
https://www.nea.com/team?unit=operations#filters
Is it Friday yet? How many more BBS prerecorded videos should we expect from Les?
So why would Les say the fall?
Bunch of numbnuts just trying to cover up everything.
It was supposed to be your CDMO!
>>So, we need other catalysts
You are attempting to change the point of this thread. The point is that Advent should've ALWAYS been a division of public NWBO, exactly as Peregrine did with Avid now ticker CDMO.
I've ask this question many times with never a reply.
Marker just sold their manufacturing facility to a board member for cost because the company was going broke and they needed the cash. Nice for the board member. LOL
Man oh man!!! We have arrived! It's all out in the open now after years of denial. Now the disciples job is to somehow normalize all this nonsense.
>>Of course the payments and revs are going to heavily favor Advent at this point. That is how the structure works.
...Be honest for once, disciples, what would Joan's latest article look like assuming she was sincere in her Specials rev projections?
LOL...BioHarm. You're awful. She already did it once with Cognate and now this Advent show. It's exhibitionism at its best! She thinks she's Warren Buffet but without share appreciation or shareholder love. Buffet didn't do cc's either. LOL
>>She found a way around this
How pissed would poor Joan Lappin be if she were alive today to see this?
I think we all know why.
So why'd Lappin project $100M in Specials revs by 2022?
So say it then... "Poly ICLC is not yet approved by any regulators."
>>But sometimes people make things up because they want to believe something. They get it in their head.
A lot of legacy shareholders were created off that article.
At least the moving will be easy. A few chairs and desks and good to go.
Advent.
In 2011 there was that article with LP saying they were two years away.
Smoke and Mirrors.